Is there good adherence to apixaban for extended thromboprophylaxis after major abdominal or pelvic surgery for cancer?
Apixaban demonstrates good adherence when used for extended VTE prophylaxis up to 28 days following major abdominal or pelvic cancer surgery.
Our results support good adherence with apixaban for VTE prophylaxis up to 28 days after major abdominal or pelvic cancer surgery.
Schulman et al. (Fri,) studied this question.